BridgePort Financial Solutions, LLC
Source: SEC Form 13F · as of Mar 2026BridgePort Financial Solutions, LLC holds 13 biotech & pharma companies tracked by BioSniper, totaling $10.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$10.8M
| Company | Shares | Value |
|---|---|---|
| PFEPFIZER INC | 131,024 | $3.7M |
| JNJJOHNSON & JOHNSON | 4,891 | $1.2M |
| MRKMerck & Co., Inc. | 9,316 | $1.1M |
| BMYBRISTOL MYERS SQUIBB CO | 13,547 | $822K |
| LLYELI LILLY & Co | 689 | $633K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 1,233 | $551K |
| AMGNAMGEN INC | 1,537 | $541K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 8,655 | $478K |
| GILDGILEAD SCIENCES, INC. | 3,169 | $442K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,559 | $422K |
| AZNASTRAZENECA PLC | 1,894 | $373K |
| NVONovo Nordisk A/S | 7,647 | $281K |
| ABTABBOTT LABORATORIES | 2,616 | $269K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.